Drug Shortage Report for DEXTROSE INJECTION USP

Last updated on 2022-01-14 History
Report ID 152746
Drug Identification Number 00037974
Brand name DEXTROSE INJECTION USP
Common or Proper name DEXTROSE INJECTION USP
Company Name ICU MEDICAL CANADA INC
Market Status MARKETED
Active Ingredient(s) DEXTROSE
Strength(s) 500MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 500 mL
ATC code B05BA
ATC description I.V. SOLUTIONS
Reason for shortage Demand increase for the drug.
Anticipated start date 2022-01-13
Actual start date
Estimated end date 2022-03-31
Actual end date
Shortage status Actual shortage
Updated date 2022-01-14
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 2600 BOUL ALFRED-NOBEL, SUITE 100
SAINT LAURENT, QUEBEC
CANADA H4S 0A9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v3 2022-01-14 English Compare
v2 2022-01-13 French Compare
v1 2022-01-13 English Compare

Showing 1 to 3 of 3